Health Condition 1: E282- Polycystic ovarian syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of reproductive age groups of 14- 45 years 2. Females from all religion and socio- economic strata. 3. Patient satisfying the Rotterdam Criteria. 4. Subject willing to give written informed consent by participants and parents or guardians under 18 years. 5. No use of birth control pill for at least 3 months before the study. 6. Patient willing to undergo individualized homeopathic treatment and follow-up regularly for study duration.
Exclusion criteria
Exclusion criteria: 1. Age below 14 years and after 45 years. 2. patients on chemotherapy. 3. Patient suffering from any severe PID disease. 4. Pregnant, lactating (less than 6 months) and puerperal women. 5. Undergoing homoeopathic treatment for any chronic disease from other physician. 6. Patient unable to provide consent or commit to regular follow-up. 7. Simultaneously taking part in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of individualized homoeopathic medicines in patients of PCOS based on improvement in menstrual irregularities and associated clinical symptoms, assessed at baseline and end of study.Timepoint: 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures will include assessment of changes in ultrasonographic findings, improvement in associated symptoms of Polycystic Ovary Syndrome such as acne, hirsutism, obesity and hair fall, along with evaluation of BMI and miasmatic correlation during the treatment period.Timepoint: 24 weeks | — |
Countries
India
Contacts
R.B.T.S. Government Homoeopathic medical college and hospital